Literature DB >> 3871844

Electrical stimulation of the brain in treatment of chronic pain. Experience over 5 years.

R F Young, R Kroening, W Fulton, R A Feldman, I Chambi.   

Abstract

Forty-eight patients underwent electrical stimulation of the brain for treatment of chronic pain between 1978 and 1983. Average pain duration prior to treatment was 4.5 years. Before selection for this procedure patients underwent pain treatment in a multidisciplinary pain center, intensive psychological and psychiatric evaluation, and assessment of pain responsiveness to intravenous administration of placebo, morphine, and naloxone. A total of 71 electrodes were placed in the 48 patients at a variety of stimulating targets, including the periaqueductal gray matter, periventricular gray matter, thalamus, and internal capsule. Seventy-two percent of patients experienced complete or partial pain relief. In addition, 59% of patients were able to discontinue narcotic usage. Twenty-five percent of patients returned to normal physical activities and another 33% showed marked improvement in functional capacity. Follow-up periods ranged from 2 to 60 months; with a mean follow-up period of 20 months. A variety of relatively minor complications occurred, but no mortality or permanent sequelae were experienced. No patient's pain was made worse as a result of electrical stimulation. Electrical stimulation of the brain offers a safe and relatively effective method for the treatment of chronic pain in appropriately selected patients, who are unresponsive to other forms of therapy.

Entities:  

Mesh:

Year:  1985        PMID: 3871844     DOI: 10.3171/jns.1985.62.3.0389

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  17 in total

Review 1.  Dopamine tunes prefrontal outputs to orchestrate aversive processing.

Authors:  Caitlin M Vander Weele; Cody A Siciliano; Kay M Tye
Journal:  Brain Res       Date:  2018-12-01       Impact factor: 3.252

2.  The use of low voltage electric therapy in the treatment of 'Graves ophthalmopathy'.

Authors:  O Fakhri
Journal:  Int Ophthalmol       Date:  1991-05       Impact factor: 2.031

3.  Targeting the brain: considerations in 332 consecutive patients treated by deep brain stimulation (DBS) for severe neurological diseases.

Authors:  Angelo Franzini; Roberto Cordella; Giuseppe Messina; Carlo Efisio Marras; Luigi Michele Romito; Alberto Albanese; Michele Rizzi; Nardo Nardocci; Giovanna Zorzi; Edvin Zekaj; Flavio Villani; Massimo Leone; Orsola Gambini; Giovanni Broggi
Journal:  Neurol Sci       Date:  2012-01-24       Impact factor: 3.307

4.  Neurosurgery: chronic benign pain management.

Authors:  R F Young
Journal:  West J Med       Date:  1986-07

5.  Common representation of pain and negative emotion in the midbrain periaqueductal gray.

Authors:  Jason T Buhle; Hedy Kober; Kevin N Ochsner; Peter Mende-Siedlecki; Jochen Weber; Brent L Hughes; Ethan Kross; Lauren Y Atlas; Kateri McRae; Tor D Wager
Journal:  Soc Cogn Affect Neurosci       Date:  2012-03-24       Impact factor: 3.436

Review 6.  Neuropathic pain and deep brain stimulation.

Authors:  Erlick A C Pereira; Tipu Z Aziz
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 7.  The recurrence of pain after neurosurgical procedures.

Authors:  R R Tasker
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

Review 8.  Invasive and non-invasive brain stimulation for treatment of neuropathic pain in patients with spinal cord injury: a review.

Authors:  Raffaele Nardone; Yvonne Höller; Stefan Leis; Peter Höller; Natasha Thon; Aljoscha Thomschewski; Stefan Golaszewski; Francesco Brigo; Eugen Trinka
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

9.  The nucleus accumbens as a potential target for central poststroke pain.

Authors:  Grant W Mallory; Osama Abulseoud; Sun-Chul Hwang; Deborah A Gorman; Squire M Stead; Bryan T Klassen; Paola Sandroni; James C Watson; Kendall H Lee
Journal:  Mayo Clin Proc       Date:  2012-09-12       Impact factor: 7.616

Review 10.  Central neuromodulation for refractory pain.

Authors:  Nina Z Moore; Scott F Lempka; Andre Machado
Journal:  Neurosurg Clin N Am       Date:  2013-10-10       Impact factor: 2.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.